Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00838695 · ClinicalTrials.gov registry record · NA
Variability in Adrenergic Response
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT00838695 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 106 participants.
The verdict
NCT00838695, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
The goal of this project is to determine the genetic factors contributing to interindividual differences in response to physiological and pharmacological vasoconstrictors and vasodilators.
Interventions
- DRUG Phenylephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00838695
The ClinicalTrials.gov registry entry for NCT00838695 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Phenylephrine is the first listed.
NCT00838695 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00838695 about?
NCT00838695 is a clinical study titled "Variability in Adrenergic Response". The goal of this project is to determine the genetic factors contributing to interindividual differences in response to physiological and pharmacological vasoconstrictors and vasodilators.
What is the current status of trial NCT00838695?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2009-01. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00838695?
The interventions under investigation include: Phenylephrine (DRUG).
Who is sponsoring clinical trial NCT00838695?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.